_id
691847d93c536f8df2317869
Ticker
ZYME
Name
Zymeworks Inc. Common Stock
Exchange
NASDAQ
Address
108 Patriot Drive, Middletown, DE, United States, 19709
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.zymeworks.com
Description
Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID). Its therapeutic platforms and fully integrated drug development engine provides the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies that enable the selective modulation of recruited cytotoxic immune cells for various therapeutic applications; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead product candidate consists of zanidatamab, a novel bispecific antibody that targets human epidermal growth factor receptor 2 HER2 that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. In addition, the company develops a pipeline of preclinical product candidates. It has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is based in Middletown, Delaware.
Last Close
24.94
Volume
614907
Current Price
25.48
Change
2.1651964715316727
Last Updated
2025-12-05T14:21:20.300Z
Image
https://logo.clearbit.com/www.zymeworks.com
Ipo Date
2017-04-28T00:00:00.000Z
Market Cap
2008502400
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.6622733333333333
Sentiment Sources
30
Rating
4.5
Target Price
34.5
Strong Buy
7
Buy
1
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
27614000
Cost Of Revenue
-
Gross Profit
27614000
Operating Expenses
49724000
Operating Income
-22110000
Interest Expense
-
Pretax Income
-18266000
Net Income
-19602000
Eps
-0.2586861714438708
Dividends Per Share
-
Shares Outstanding
74836534
Income Tax Expense
1336000
EBITDA
-15682000
Operating Margin
-80.06808140798147
Total Other Income Expense Net
3844000
Cash
64834000
Short Term Investments
187099000
Receivables
29352000
Inventories
-
Total Current Assets
291712000
Property Plant Equipment
32467000
Total Assets
397269000
Payables
1305000
Short Term Debt
3400000
Long Term Debt
-
Total Liabilities
77205000
Equity
320064000
Depreciation
2584000
Change In Working Capital
-20684000
Cash From Operations
-31412000
Capital Expenditures
410000
Cash From Investing
368000
Cash From Financing
-2452000
Net Change In Cash
-33419000
PE
-
PB
6.032394935762848
ROE
-6.124400119976005
ROA
-4.934188169728824
FCF
-31822000
Fcf Percent
-1.1523864706308393
Piotroski FScore
0
Health Score
26
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
27614000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
27614000
Quarters > 0 > income Statement > operating Expenses
49724000
Quarters > 0 > income Statement > operating Income
-22110000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-18266000
Quarters > 0 > income Statement > net Income
-19602000
Quarters > 0 > income Statement > eps
-0.2586861714438708
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
75775214
Quarters > 0 > income Statement > income Tax Expense
1336000
Quarters > 0 > income Statement > EBITDA
-15682000
Quarters > 0 > income Statement > operating Margin
-80.06808140798147
Quarters > 0 > income Statement > total Other Income Expense Net
3844000
Quarters > 0 > balance Sheet > cash
64834000
Quarters > 0 > balance Sheet > short Term Investments
187099000
Quarters > 0 > balance Sheet > receivables
29352000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
291712000
Quarters > 0 > balance Sheet > property Plant Equipment
32467000
Quarters > 0 > balance Sheet > total Assets
397269000
Quarters > 0 > balance Sheet > payables
1305000
Quarters > 0 > balance Sheet > short Term Debt
3400000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
77205000
Quarters > 0 > balance Sheet > equity
320064000
Quarters > 0 > cash Flow > net Income
-19602000
Quarters > 0 > cash Flow > depreciation
2584000
Quarters > 0 > cash Flow > change In Working Capital
-20684000
Quarters > 0 > cash Flow > cash From Operations
-31412000
Quarters > 0 > cash Flow > capital Expenditures
410000
Quarters > 0 > cash Flow > cash From Investing
368000
Quarters > 0 > cash Flow > cash From Financing
-2452000
Quarters > 0 > cash Flow > net Change In Cash
-33419000
Quarters > 0 > ratios > PE
-0.2586861714438708
Quarters > 0 > ratios > PB
6.032394935762848
Quarters > 0 > ratios > ROE
-6.124400119976005
Quarters > 0 > ratios > ROA
-4.934188169728824
Quarters > 0 > ratios > FCF
-31822000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.1523864706308393
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
48726000
Quarters > 1 > income Statement > cost Of Revenue
3214000
Quarters > 1 > income Statement > gross Profit
48726000
Quarters > 1 > income Statement > operating Expenses
49400000
Quarters > 1 > income Statement > operating Income
-674000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
2131000
Quarters > 1 > income Statement > net Income
2317000
Quarters > 1 > income Statement > eps
0.029943737952152542
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
77378449
Quarters > 1 > income Statement > income Tax Expense
-186000
Quarters > 1 > income Statement > EBITDA
2591000
Quarters > 1 > income Statement > operating Margin
-1.3832450847596764
Quarters > 1 > income Statement > total Other Income Expense Net
2805000
Quarters > 1 > balance Sheet > cash
98253000
Quarters > 1 > balance Sheet > short Term Investments
183126000
Quarters > 1 > balance Sheet > receivables
2631000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
296130000
Quarters > 1 > balance Sheet > property Plant Equipment
32574000
Quarters > 1 > balance Sheet > total Assets
408385000
Quarters > 1 > balance Sheet > payables
32000
Quarters > 1 > balance Sheet > short Term Debt
3586000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
73879000
Quarters > 1 > balance Sheet > equity
334506000
Quarters > 1 > cash Flow > net Income
2317000
Quarters > 1 > cash Flow > depreciation
3214000
Quarters > 1 > cash Flow > change In Working Capital
-154000
Quarters > 1 > cash Flow > cash From Operations
12073000
Quarters > 1 > cash Flow > capital Expenditures
884000
Quarters > 1 > cash Flow > cash From Investing
8745000
Quarters > 1 > cash Flow > cash From Financing
1319000
Quarters > 1 > cash Flow > net Change In Cash
22049000
Quarters > 1 > ratios > PE
0.029943737952152542
Quarters > 1 > ratios > PB
5.89407329171973
Quarters > 1 > ratios > ROE
0.69266321082432
Quarters > 1 > ratios > ROA
0.5673567834274031
Quarters > 1 > ratios > FCF
11189000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.22963099782457005
Quarters > 1 > health Score
66
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
27110000
Quarters > 2 > income Statement > cost Of Revenue
3305000
Quarters > 2 > income Statement > gross Profit
27110000
Quarters > 2 > income Statement > operating Expenses
52723000
Quarters > 2 > income Statement > operating Income
-25613000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-22140000
Quarters > 2 > income Statement > net Income
-22636000
Quarters > 2 > income Statement > eps
-0.3009050534355717
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
75226387
Quarters > 2 > income Statement > income Tax Expense
496000
Quarters > 2 > income Statement > EBITDA
-22323000
Quarters > 2 > income Statement > operating Margin
-94.47805237919586
Quarters > 2 > income Statement > total Other Income Expense Net
3473000
Quarters > 2 > balance Sheet > cash
76204000
Quarters > 2 > balance Sheet > short Term Investments
189083000
Quarters > 2 > balance Sheet > receivables
24594000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
306467000
Quarters > 2 > balance Sheet > property Plant Equipment
33408000
Quarters > 2 > balance Sheet > total Assets
425522000
Quarters > 2 > balance Sheet > payables
5223000
Quarters > 2 > balance Sheet > short Term Debt
3258000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
100555000
Quarters > 2 > balance Sheet > equity
324967000
Quarters > 2 > cash Flow > net Income
-22636000
Quarters > 2 > cash Flow > depreciation
3305000
Quarters > 2 > cash Flow > change In Working Capital
9964000
Quarters > 2 > cash Flow > cash From Operations
-3407000
Quarters > 2 > cash Flow > capital Expenditures
338000
Quarters > 2 > cash Flow > cash From Investing
12182000
Quarters > 2 > cash Flow > cash From Financing
1316000
Quarters > 2 > cash Flow > net Change In Cash
10101000
Quarters > 2 > ratios > PE
-0.3009050534355717
Quarters > 2 > ratios > PB
5.898347649945994
Quarters > 2 > ratios > ROE
-6.9656303563131035
Quarters > 2 > ratios > ROA
-5.319583946305949
Quarters > 2 > ratios > FCF
-3745000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.1381409074142383
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
31031000
Quarters > 3 > income Statement > cost Of Revenue
-26741000
Quarters > 3 > income Statement > gross Profit
31031000
Quarters > 3 > income Statement > operating Expenses
53248000
Quarters > 3 > income Statement > operating Income
-22217000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-17791000
Quarters > 3 > income Statement > net Income
-23506000
Quarters > 3 > income Statement > eps
-0.3097837499616823
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
75878738
Quarters > 3 > income Statement > income Tax Expense
5715000
Quarters > 3 > income Statement > EBITDA
-18543000
Quarters > 3 > income Statement > operating Margin
-71.59614578969418
Quarters > 3 > income Statement > total Other Income Expense Net
4426000
Quarters > 3 > balance Sheet > cash
66103000
Quarters > 3 > balance Sheet > short Term Investments
159673000
Quarters > 3 > balance Sheet > receivables
55815000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
300451000
Quarters > 3 > balance Sheet > property Plant Equipment
34316000
Quarters > 3 > balance Sheet > total Assets
463091000
Quarters > 3 > balance Sheet > payables
3903000
Quarters > 3 > balance Sheet > short Term Debt
2740000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
124323000
Quarters > 3 > balance Sheet > equity
338768000
Quarters > 3 > cash Flow > net Income
-23506000
Quarters > 3 > cash Flow > depreciation
3689000
Quarters > 3 > cash Flow > change In Working Capital
-26946000
Quarters > 3 > cash Flow > cash From Operations
-41508000
Quarters > 3 > cash Flow > capital Expenditures
314000
Quarters > 3 > cash Flow > cash From Investing
-6214000
Quarters > 3 > cash Flow > cash From Financing
-8644000
Quarters > 3 > cash Flow > net Change In Cash
-56253000
Quarters > 3 > ratios > PE
-0.3097837499616823
Quarters > 3 > ratios > PB
5.707121818589713
Quarters > 3 > ratios > ROE
-6.938671893449204
Quarters > 3 > ratios > ROA
-5.075892211250057
Quarters > 3 > ratios > FCF
-41822000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.34774902516838
Quarters > 3 > health Score
29
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
76304000
Annuals > 0 > income Statement > cost Of Revenue
11193000
Annuals > 0 > income Statement > gross Profit
76304000
Annuals > 0 > income Statement > operating Expenses
213414000
Annuals > 0 > income Statement > operating Income
-137110000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-116611000
Annuals > 0 > income Statement > net Income
-122695000
Annuals > 0 > income Statement > eps
-1.6169878840104062
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
75878738
Annuals > 0 > income Statement > income Tax Expense
6084000
Annuals > 0 > income Statement > EBITDA
-108624000
Annuals > 0 > income Statement > operating Margin
-179.68913818410567
Annuals > 0 > income Statement > total Other Income Expense Net
20499000
Annuals > 0 > balance Sheet > cash
66103000
Annuals > 0 > balance Sheet > short Term Investments
159673000
Annuals > 0 > balance Sheet > receivables
55815000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
300451000
Annuals > 0 > balance Sheet > property Plant Equipment
34316000
Annuals > 0 > balance Sheet > total Assets
463091000
Annuals > 0 > balance Sheet > payables
3903000
Annuals > 0 > balance Sheet > short Term Debt
2740000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
124323000
Annuals > 0 > balance Sheet > equity
338768000
Annuals > 0 > cash Flow > net Income
-122695000
Annuals > 0 > cash Flow > depreciation
11193000
Annuals > 0 > cash Flow > change In Working Capital
-30953000
Annuals > 0 > cash Flow > cash From Operations
-110044000
Annuals > 0 > cash Flow > capital Expenditures
3066000
Annuals > 0 > cash Flow > cash From Investing
38756000
Annuals > 0 > cash Flow > cash From Financing
-20452000
Annuals > 0 > cash Flow > net Change In Cash
-91454000
Annuals > 0 > ratios > PE
-1.6169878840104062
Annuals > 0 > ratios > PB
5.940065566287252
Annuals > 0 > ratios > ROE
-36.218001700278656
Annuals > 0 > ratios > ROA
-26.4947926001585
Annuals > 0 > ratios > FCF
-113110000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.4823600335500104
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
76012000
Annuals > 1 > income Statement > cost Of Revenue
142989000
Annuals > 1 > income Statement > gross Profit
-66977000
Annuals > 1 > income Statement > operating Expenses
71076000
Annuals > 1 > income Statement > operating Income
-138053000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-119242000
Annuals > 1 > income Statement > net Income
-118674000
Annuals > 1 > income Statement > eps
-1.723334486831174
Annuals > 1 > income Statement > dividends Per Share
814174000
Annuals > 1 > income Statement > shares Outstanding
68863010
Annuals > 1 > income Statement > income Tax Expense
-568000
Annuals > 1 > income Statement > EBITDA
-120702000
Annuals > 1 > income Statement > operating Margin
-181.6200073672578
Annuals > 1 > income Statement > total Other Income Expense Net
18811000
Annuals > 1 > balance Sheet > cash
157557000
Annuals > 1 > balance Sheet > short Term Investments
216770000
Annuals > 1 > balance Sheet > receivables
19477000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
412926000
Annuals > 1 > balance Sheet > property Plant Equipment
37543000
Annuals > 1 > balance Sheet > total Assets
580880000
Annuals > 1 > balance Sheet > payables
6212000
Annuals > 1 > balance Sheet > short Term Debt
4261000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
116074000
Annuals > 1 > balance Sheet > equity
464806000
Annuals > 1 > cash Flow > net Income
-118674000
Annuals > 1 > cash Flow > depreciation
17305000
Annuals > 1 > cash Flow > change In Working Capital
-25545000
Annuals > 1 > cash Flow > cash From Operations
-118303000
Annuals > 1 > cash Flow > capital Expenditures
4077000
Annuals > 1 > cash Flow > cash From Investing
-207253000
Annuals > 1 > cash Flow > cash From Financing
81847000
Annuals > 1 > cash Flow > net Change In Cash
-243355000
Annuals > 1 > ratios > PE
-1.723334486831174
Annuals > 1 > ratios > PB
3.9290521748858662
Annuals > 1 > ratios > ROE
-25.53194235874752
Annuals > 1 > ratios > ROA
-20.43003718496075
Annuals > 1 > ratios > FCF
-122380000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.6100089459559017
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
412482000
Annuals > 2 > income Statement > cost Of Revenue
208703000
Annuals > 2 > income Statement > gross Profit
412482000
Annuals > 2 > income Statement > operating Expenses
281954000
Annuals > 2 > income Statement > operating Income
130528000
Annuals > 2 > income Statement > interest Expense
3596000
Annuals > 2 > income Statement > pretax Income
135234000
Annuals > 2 > income Statement > net Income
124341000
Annuals > 2 > income Statement > eps
1.9056330267670474
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
65249184
Annuals > 2 > income Statement > income Tax Expense
10893000
Annuals > 2 > income Statement > EBITDA
142532000
Annuals > 2 > income Statement > operating Margin
31.644532367473005
Annuals > 2 > income Statement > total Other Income Expense Net
4706000
Annuals > 2 > balance Sheet > cash
400912000
Annuals > 2 > balance Sheet > short Term Investments
91320000
Annuals > 2 > balance Sheet > receivables
33400000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
544706000
Annuals > 2 > balance Sheet > property Plant Equipment
47650000
Annuals > 2 > balance Sheet > total Assets
648725000
Annuals > 2 > balance Sheet > payables
7863000
Annuals > 2 > balance Sheet > short Term Debt
3322000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
155769000
Annuals > 2 > balance Sheet > equity
492956000
Annuals > 2 > cash Flow > net Income
124341000
Annuals > 2 > cash Flow > depreciation
12004000
Annuals > 2 > cash Flow > change In Working Capital
4015000
Annuals > 2 > cash Flow > cash From Operations
144109000
Annuals > 2 > cash Flow > capital Expenditures
13125000
Annuals > 2 > cash Flow > cash From Investing
-53849000
Annuals > 2 > cash Flow > cash From Financing
108582000
Annuals > 2 > cash Flow > net Change In Cash
199045000
Annuals > 2 > ratios > PE
1.9056330267670474
Annuals > 2 > ratios > PB
3.510269394590998
Annuals > 2 > ratios > ROE
25.223549363432028
Annuals > 2 > ratios > ROA
19.166981386565958
Annuals > 2 > ratios > FCF
130984000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.31755082646030613
Annuals > 2 > health Score
89
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
26680000
Annuals > 3 > income Statement > cost Of Revenue
199539000
Annuals > 3 > income Statement > gross Profit
26680000
Annuals > 3 > income Statement > operating Expenses
242313000
Annuals > 3 > income Statement > operating Income
-215633000
Annuals > 3 > income Statement > interest Expense
12857000
Annuals > 3 > income Statement > pretax Income
-212359000
Annuals > 3 > income Statement > net Income
-211843000
Annuals > 3 > income Statement > eps
-4.06362007409096
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
52131596
Annuals > 3 > income Statement > income Tax Expense
-516000
Annuals > 3 > income Statement > EBITDA
-206050000
Annuals > 3 > income Statement > operating Margin
-808.21964017991
Annuals > 3 > income Statement > total Other Income Expense Net
3274000
Annuals > 3 > balance Sheet > cash
201867000
Annuals > 3 > balance Sheet > short Term Investments
50741000
Annuals > 3 > balance Sheet > receivables
15614000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
288220000
Annuals > 3 > balance Sheet > property Plant Equipment
49770000
Annuals > 3 > balance Sheet > total Assets
389132000
Annuals > 3 > balance Sheet > payables
5174000
Annuals > 3 > balance Sheet > short Term Debt
1310000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
140038000
Annuals > 3 > balance Sheet > equity
249094000
Annuals > 3 > cash Flow > net Income
-211843000
Annuals > 3 > cash Flow > depreciation
9583000
Annuals > 3 > cash Flow > change In Working Capital
393000
Annuals > 3 > cash Flow > cash From Operations
-192451000
Annuals > 3 > cash Flow > capital Expenditures
13285000
Annuals > 3 > cash Flow > cash From Investing
144596000
Annuals > 3 > cash Flow > cash From Financing
8011000
Annuals > 3 > cash Flow > net Change In Cash
-40169000
Annuals > 3 > ratios > PE
-4.06362007409096
Annuals > 3 > ratios > PB
5.550233750792873
Annuals > 3 > ratios > ROE
-85.04540454607498
Annuals > 3 > ratios > ROA
-54.43988158259923
Annuals > 3 > ratios > FCF
-205736000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-7.711244377811094
Annuals > 3 > health Score
25
Valuation > metrics > PE
-0.2586861714438708
Valuation > metrics > PB
6.032394935762848
Valuation > final Score
20
Valuation > verdict
101.1% Overvalued
Profitability > metrics > ROE
-6.124400119976005
Profitability > metrics > ROA
-6.71964129003949
Profitability > metrics > Net Margin
-0.709857318751358
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.24121738152369526
Risk > metrics > Interest Coverage
-8.556501547987617
Risk > final Score
26
Risk > verdict
High
Liquidity > metrics > Current Ratio
62.000425079702445
Liquidity > metrics > Quick Ratio
62.000425079702445
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
41.059267082802705
Prev Valuations > 1
21.01652350054006
Prev Valuations > 2
22.92878181410287
Prev Profitabilities > 0
11
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
54
Prev Risks > 1
-500
Prev Risks > 2
-58
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:39:34.863Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.26
Earnings History > 0 > eps Estimate
-0.3164
Earnings History > 0 > eps Difference
0.0564
Earnings History > 0 > surprise Percent
17.8255
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0.03
Earnings History > 1 > eps Estimate
-0.46
Earnings History > 1 > eps Difference
0.49
Earnings History > 1 > surprise Percent
106.5217
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.3
Earnings History > 2 > eps Estimate
-0.73
Earnings History > 2 > eps Difference
0.43
Earnings History > 2 > surprise Percent
58.9041
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-04
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.31
Earnings History > 3 > eps Estimate
-0.0922
Earnings History > 3 > eps Difference
-0.2178
Earnings History > 3 > surprise Percent
-236.2256
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-31
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.39
Earnings History > 4 > eps Estimate
-0.41
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
4.878
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.49
Earnings History > 5 > eps Estimate
-0.31
Earnings History > 5 > eps Difference
-0.18
Earnings History > 5 > surprise Percent
-58.0645
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.42
Earnings History > 6 > eps Estimate
-0.29
Earnings History > 6 > eps Difference
-0.13
Earnings History > 6 > surprise Percent
-44.8276
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-06
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2
Earnings History > 7 > eps Estimate
-0.43
Earnings History > 7 > eps Difference
0.23
Earnings History > 7 > surprise Percent
53.4884
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.41
Earnings History > 8 > eps Estimate
-0.47
Earnings History > 8 > eps Difference
0.06
Earnings History > 8 > surprise Percent
12.766
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.76
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
-0.29
Earnings History > 9 > surprise Percent
-61.7021
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-08
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.36
Earnings History > 10 > eps Estimate
-0.54
Earnings History > 10 > eps Difference
0.18
Earnings History > 10 > surprise Percent
33.3333
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-07
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
4.65
Earnings History > 11 > eps Estimate
4.84
Earnings History > 11 > eps Difference
-0.19
Earnings History > 11 > surprise Percent
-3.9256
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.72
Earnings History > 12 > eps Estimate
-0.97
Earnings History > 12 > eps Difference
0.25
Earnings History > 12 > surprise Percent
25.7732
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.97
Earnings History > 13 > eps Estimate
-0.94
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-3.1915
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-04
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.19
Earnings History > 14 > eps Estimate
-0.76
Earnings History > 14 > eps Difference
-0.43
Earnings History > 14 > surprise Percent
-56.5789
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.76
Earnings History > 15 > eps Estimate
-1.14
Earnings History > 15 > eps Difference
0.38
Earnings History > 15 > surprise Percent
33.3333
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-03
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.17
Earnings History > 16 > eps Estimate
-1.08
Earnings History > 16 > eps Difference
-0.09
Earnings History > 16 > surprise Percent
-8.3333
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-04
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.31
Earnings History > 17 > eps Estimate
-1.04
Earnings History > 17 > eps Difference
-0.27
Earnings History > 17 > surprise Percent
-25.9615
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-05
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.87
Earnings History > 18 > eps Estimate
-1.05
Earnings History > 18 > eps Difference
0.18
Earnings History > 18 > surprise Percent
17.1429
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-24
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.74
Earnings History > 19 > eps Estimate
-1.22
Earnings History > 19 > eps Difference
0.48
Earnings History > 19 > surprise Percent
39.3443
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-03
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.43
Earnings History > 20 > eps Estimate
-0.99
Earnings History > 20 > eps Difference
-0.44
Earnings History > 20 > surprise Percent
-44.4444
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-05
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.77
Earnings History > 21 > eps Estimate
-0.87
Earnings History > 21 > eps Difference
0.1
Earnings History > 21 > surprise Percent
11.4943
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.64
Earnings History > 22 > eps Estimate
-1.07
Earnings History > 22 > eps Difference
0.43
Earnings History > 22 > surprise Percent
40.1869
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-02
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.66
Earnings History > 23 > eps Estimate
-0.88
Earnings History > 23 > eps Difference
-0.78
Earnings History > 23 > surprise Percent
-88.6364
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-05
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.7
Earnings History > 24 > eps Estimate
-0.74
Earnings History > 24 > eps Difference
0.04
Earnings History > 24 > surprise Percent
5.4054
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-02
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.86
Earnings History > 25 > eps Estimate
-0.6
Earnings History > 25 > eps Difference
-0.26
Earnings History > 25 > surprise Percent
-43.3333
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-02
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.43
Earnings History > 26 > eps Estimate
-0.52
Earnings History > 26 > eps Difference
0.09
Earnings History > 26 > surprise Percent
17.3077
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-06
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0.29
Earnings History > 27 > eps Estimate
0.1
Earnings History > 27 > eps Difference
0.19
Earnings History > 27 > surprise Percent
190
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-06
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.59
Earnings History > 28 > eps Estimate
-0.64
Earnings History > 28 > eps Difference
0.05
Earnings History > 28 > surprise Percent
7.8125
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-01
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.22
Earnings History > 29 > eps Estimate
-0.33
Earnings History > 29 > eps Difference
0.11
Earnings History > 29 > surprise Percent
33.3333
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-01
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.83
Earnings History > 30 > eps Estimate
-0.67
Earnings History > 30 > eps Difference
-0.16
Earnings History > 30 > surprise Percent
-23.8806
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-14
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.68
Earnings History > 31 > eps Estimate
-0.01
Earnings History > 31 > eps Difference
-0.67
Earnings History > 31 > surprise Percent
-6700
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-08
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.64
Earnings History > 32 > eps Estimate
-0.57
Earnings History > 32 > eps Difference
-0.07
Earnings History > 32 > surprise Percent
-12.2807
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-09
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.38
Earnings History > 33 > eps Estimate
-0.54
Earnings History > 33 > eps Difference
0.16
Earnings History > 33 > surprise Percent
29.6296
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-16
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.64
Earnings History > 34 > eps Estimate
-0.59
Earnings History > 34 > eps Difference
-0.05
Earnings History > 34 > surprise Percent
-8.4746
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-01
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.36
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-0.36
Earnings History > 35 > surprise Percent
-
Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID). Its therapeutic platforms and fully integrated drug development engine provides the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies that enable the selective modulation of recruited cytotoxic immune cells for various therapeutic applications; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead product candidate consists of zanidatamab, a novel bispecific antibody that targets human epidermal growth factor receptor 2 HER2 that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. In addition, the company develops a pipeline of preclinical product candidates. It has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is based in Middletown, Delaware.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$34.5
Analyst Picks
Strong Buy
7
Buy
1
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 101.20% of the total shares of Zymeworks Inc. Common Stock
1.
EcoR1 Capital, LLC(30.3298%)
since
2025/06/30
2.
Rubric Capital Management LP(6.2197%)
since
2025/06/30
3.
Bvf Inc(5.6895%)
since
2025/06/30
4.
Morgan Stanley - Brokerage Accounts(5.5161%)
since
2025/06/30
5.
Redmile Group, LLC(5.4804%)
since
2025/06/30
6.
BlackRock Inc(5.0099%)
since
2025/06/30
7.
Vanguard Group Inc(3.2543%)
since
2025/06/30
8.
UBS Asset Mgmt Americas Inc(3.2475%)
since
2025/06/30
9.
BNP Paribas Investment Partners SA(2.6931%)
since
2025/06/30
10.
HBM Healthcare Investments AG Ord(2.6362%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(2.4364%)
since
2025/07/31
12.
Blackstone Inc(2.1876%)
since
2025/06/30
13.
Deutsche Bank AG(2.0397%)
since
2025/06/30
14.
Prosight Management, LP(1.7296%)
since
2025/06/30
15.
Perceptive Advisors LLC(1.6839%)
since
2025/06/30
16.
iShares Russell 2000 ETF(1.6074%)
since
2025/08/31
17.
Dimensional Fund Advisors, Inc.(1.5745%)
since
2025/06/30
18.
Vestal Point Capital LP(1.5184%)
since
2025/06/30
19.
Nextech Invest, Ltd.(1.4708%)
since
2025/06/30
20.
TANG CAPITAL MANAGEMENT LLC(1.4524%)
since
2025/06/30
21.
BNP Paribas US Small Cap ClassicC(1.4374%)
since
2025/07/31
22.
State Street Corp(1.4372%)
since
2025/06/30
23.
UBS Lux Dgtl Hlth Eq Fd seeding P acc(1.1153%)
since
2025/07/31
24.
BNP Paribas Health Cr Innovtr Cl Cap(1.0506%)
since
2025/07/31
25.
Xtrackers S&P 500 Swap ETF 1C(1.0225%)
since
2025/07/31
26.
Geode Capital Management, LLC(0.9314%)
since
2025/06/30
27.
Nuveen, LLC(0.8647%)
since
2025/06/30
28.
Xtrackers S&P 500 2xLev Dly Swap ETF 1C(0.8347%)
since
2025/07/31
29.
Fidelity Small Cap Index(0.6491%)
since
2025/06/30
30.
Nuveen Quant Small Cap Equity R6(0.6231%)
since
2025/07/31
31.
iShares Russell 2000 Growth ETF(0.5745%)
since
2025/08/31
32.
iShares Biotechnology ETF(0.5353%)
since
2025/08/31
33.
Jupiter Merian Glb Eq AbsRet I USD Acc(0.4449%)
since
2025/06/30
34.
DFA US Small Cap I(0.3322%)
since
2025/07/31
35.
Vanguard Russell 2000 ETF(0.3085%)
since
2025/07/31
36.
Schroder Global Healthcare A Acc(0.2913%)
since
2025/07/31
37.
Dimensional US Small Cap ETF(0.2517%)
since
2025/08/29
38.
Invesco MSCI World ETF(0.2447%)
since
2025/07/31
39.
State St Russell Sm Cap® Indx SL Cl I(0.2436%)
since
2025/08/31
40.
Federated Hermes MDT SCC Institutional(0.227%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.26
EPS Estimate
-0.3164
EPS Difference
0.0564
Surprise Percent
17.8255%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.